Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists

Abstract Background Patients with myeloproliferative neoplasms (MPNs), such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are at an increased risk of recurrent thromboembolic events (TEs) and hemorrhagic complications. Anticoagulation with vitamin K anta...

Full description

Bibliographic Details
Main Authors: Kateryna Fedorov, Swati Goel, Margarita Kushnir, Henny H. Billett
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
anticoagulants
myeloproliferative disorders
neoplasms
thrombosis
treatment outcome
Online Access:https://doi.org/10.1002/rth2.12574

Internet

https://doi.org/10.1002/rth2.12574

Similar Items